Here's the live share price of Choksi Laboratories along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Choksi Laboratories | -2.85 | -0.26 | -14.73 | -45.24 | -5.08 | 39.96 | 63.59 |
| Suven Life Sciences | 25.16 | 36.81 | 27.96 | -5.88 | 60.95 | 56.74 | 21.62 |
| Sun Pharma Advanced Research Company | 19.09 | 19.28 | 9.70 | 10.68 | 1.68 | -6.74 | -1.08 |
| Vimta Labs | 13.28 | 4.17 | -17.54 | -34.68 | 0.99 | 40.11 | 34.34 |
| Vanta Bioscience | 19.87 | -6.08 | -13.24 | -27.58 | -17.03 | -30.65 | -36.75 |
Over the last one year, Choksi Laboratories has declined 5.08% compared to peers like Suven Life Sciences (60.95%), Sun Pharma Advanced Research Company (1.68%), Vimta Labs (0.99%). From a 5 year perspective, Choksi Laboratories has outperformed peers relative to Suven Life Sciences (21.62%) and Sun Pharma Advanced Research Company (-1.08%).
| Day | SMA | EMA |
|---|---|---|
| 5 | 99.74 | 99.06 |
| 10 | 103.55 | 100.37 |
| 20 | 101.75 | 102.01 |
| 50 | 108.38 | 107.62 |
| 100 | 117.38 | 118.75 |
| 200 | 151.84 | 128.58 |
In the latest quarter, Choksi Laboratories remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding rose to 6.03%, and public shareholding moved down to 62.49% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Date Time | Announcement |
|---|---|
| Apr 07, 2026, 09:18 PM IST IST | Choksi Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Mar 26, 2026, 05:24 PM IST IST | Choksi Laboratories - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot |
| Feb 07, 2026, 10:24 PM IST IST | Choksi Laboratories - Intimation Of Re-Constitution Of Various Committees Of Board Of Directors Under Regulation 30 Of SEBI ( |
| Feb 07, 2026, 08:39 PM IST IST | Choksi Laboratories - Announcement under Regulation 30 (LODR)-Change in Management |
| Feb 07, 2026, 08:29 PM IST IST | Choksi Laboratories - Financial Result For The Quarter And Nine Month Ended 31.12.2025 |
Choksi Laboratories Ltd. is a Public Limited Listed company incorporated on 29/01/1993 and has its registered office in the State of Madhya Pradesh, India. Company's Corporate Identification Number(CIN) is L85195MP1993PLC007471 and registration number is 007471. Currently company belongs to the Industry of Medical Research Services. Company's Total Operating Revenue is Rs. 41.78 Cr. and Equity Capital is Rs. 6.97 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Choksi Laboratories is ₹97.25 as on Apr 10, 2026.
The Choksi Laboratories is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
The market cap of Choksi Laboratories is ₹67.74 Cr as on Apr 10, 2026.
Today’s highest and lowest price of Choksi Laboratories are ₹104.80 and ₹96.55.
The 52-week high/low is the highest and lowest price at which Choksi Laboratories stock has traded in the past 52-week or nearly a year. The 52-week high of Choksi Laboratories is ₹236.70 and 52-week low of Choksi Laboratories is ₹81.85 as on Apr 10, 2026.
The Choksi Laboratories has shown returns of -2.6% over the past day, -0.26% for the past month, -14.73% over 3 months, -5.08% over 1 year, 39.96% across 3 years, and 63.59% over 5 years.
P/E ratio of and PB ratio of Choksi Laboratories are 36.45 and 2.73 on Apr 10, 2026. While the company gives a dividend yield of 0.00 per annum.